Lau Colleen L, Won Kimberly Y, Lammie Patrick J, Graves Patricia M
Department of Global Health, Research School of Population Health, Australian National University, Canberra, Australia.
Centers for Disease Control and Prevention, Division of Parasitic Diseases and Malaria, Atlanta, United States of America.
PLoS Negl Trop Dis. 2016 Nov 1;10(11):e0005108. doi: 10.1371/journal.pntd.0005108. eCollection 2016 Nov.
The Global Programme to Eliminate Lymphatic Filariasis has made significant progress toward interrupting transmission of lymphatic filariasis (LF) through mass drug administration (MDA). Operational challenges in defining endpoints of elimination programs include the need to determine appropriate post-MDA surveillance strategies. As humans are the only reservoirs of LF parasites, one such strategy is molecular xenomonitoring (MX), the detection of filarial DNA in mosquitoes using molecular methods (PCR), to provide an indirect indicator of infected persons nearby. MX could potentially be used to evaluate program success, provide support for decisions to stop MDA, and conduct post-MDA surveillance. American Samoa has successfully completed MDA and passed WHO recommended Transmission Assessment Surveys in 2011 and 2015, but recent studies using spatial analysis of antigen (Ag) and antibody (Ab) prevalence in adults (aged ≥18 years) and entomological surveys showed evidence of possible ongoing transmission. This study evaluated MX as a surveillance tool in American Samoa by linking village-level results of published human and mosquito studies. Of 32 villages, seropositive persons for Og4C3 Ag were identified in 11 (34.4%), for Wb123 Ab in 18 (56.3%) and for Bm14 Ab in 27 (84.4%) of villages. Village-level seroprevalence ranged from 0-33%, 0-67% and 0-100% for Og4C3 Ag, Wb123 Ab and Bm14 Ab respectively. PCR-positive Aedes polynesiensis mosquitoes were found in 15 (47%) villages, and their presence was significantly associated with seropositive persons for Og4C3 Ag (67% vs 6%, p<0.001) and Wb123 Ab (87% vs 29%, p = 0.001), but not Bm14 Ab. In villages with persons seropositive for Og4C3 Ag and Wb123 Ab, PCR-positive Ae. polynesiensis were found in 90.9% and 72.2% respectively. In villages without seropositive persons for Og4C3 Ag or Wb123 Ab, PCR-positive Ae. polynesiensis were also absent in 94.1% and 70.6% of villages respectively. Our study provides promising evidence to support the potential usefulness of MX in post-MDA surveillance in an Aedes transmission area in the Pacific Islands setting.
全球消除淋巴丝虫病规划通过大规模药物治疗(MDA)在阻断淋巴丝虫病(LF)传播方面取得了重大进展。消除规划确定终点的操作挑战包括需要确定MDA后的适当监测策略。由于人类是LF寄生虫的唯一宿主,一种这样的策略是分子异体监测(MX),即使用分子方法(PCR)检测蚊子体内的丝虫DNA,以间接指示附近受感染的人。MX有可能用于评估规划的成功与否,为停止MDA的决策提供支持,并进行MDA后的监测。美属萨摩亚已成功完成MDA,并在2011年和2015年通过了世界卫生组织推荐的传播评估调查,但最近利用成人(≥18岁)抗原(Ag)和抗体(Ab)流行率的空间分析以及昆虫学调查的研究显示有持续传播的可能迹象。本研究通过将已发表的人类和蚊子研究的村级结果联系起来,评估了MX作为美属萨摩亚监测工具的情况。在32个村庄中,11个村庄(34.4%)发现了Og4C3 Ag血清阳性者,18个村庄(56.3%)发现了Wb123 Ab血清阳性者,27个村庄(84.4%)发现了Bm14 Ab血清阳性者。Og4C3 Ag、Wb123 Ab和Bm14 Ab的村级血清流行率分别为0 - 33%、0 - 67%和0 - 100%。在15个村庄(47%)发现了PCR阳性的波利尼西亚伊蚊,其存在与Og4C3 Ag血清阳性者(分别为67%和6%,p<0.001)和Wb123 Ab血清阳性者(分别为87%和29%,p = 0.001)显著相关,但与Bm14 Ab无关。在有Og4C3 Ag和Wb123 Ab血清阳性者的村庄中,分别有90.9%和72.2%发现了PCR阳性的波利尼西亚伊蚊。在没有Og4C3 Ag或Wb123 Ab血清阳性者的村庄中,分别有94.1%和70.6%的村庄也没有PCR阳性的波利尼西亚伊蚊。我们的研究提供了有前景的证据,支持MX在太平洋岛屿环境中伊蚊传播地区MDA后监测中的潜在用途。